25 Jan 2022
Happening soon! Tune in at 10:00 AM ET/ 4:00 PM CET for a special discussion geared towards #molpath professionals practicing outside the U.S. during the COVID-19 pandemic. This free event is open to all! #AMPath21 ow.ly/eoBA50HyXfk
2
3
22 Jan 2022
Join us on January 25 (10:00 AM ET/ 4:00 PM CET) for a special discussion geared towards molecular professionals practicing outside the U.S. during the COVID-19 pandemic. This free event is open to all! #AMPath21 #IDTwitter #pathtwitter #molpath ow.ly/eoBA50HyXfk
1
1
2
20 Jan 2022
Join us on January 25 for a special discussion geared towards #molpath professionals practicing outside the U.S. during the COVID-19 pandemic. With participants joining from Lebanon, Italy and Germany, this free event is open to all! #AMPath21 #IDTwitter ow.ly/7eLq50HyXfm
3
6
19 Jan 2022
Join AMP tomorrow at 1:30 PM ET for a live Q& A with Jennifer Doudna, PhD. We look forward to discussing her #AMPath21 lecture, "CRISPRology: Science and Ethics of Genome Editing." Register: ow.ly/V2Wv50Hxj4x (NOTE: this event is open to "FULL" event registrants only.)
5
10
18 Jan 2022
The full #AMPath21 Digital Experience is now available! Become a members to purchase the package at a significant discount. As a reminder, Associate Membership is FREE for qualifying students, residents and postdocs! ow.ly/rIK550HxjVi #pathtwitter
1
3
18 Jan 2022
#AMPath21 FULL registrants – we are pleased to announce a LIVE Q&A with Jennifer Doudna, PhD on January 20 at 1:30 PM ET. We look forward to discussing her lecture, "#CRISPR-ology: Science & Ethics of Genome Editing," and hope to "see" you there! ow.ly/rxrh50HxiJZ #molpath
1
5
7
30 Nov 2021
#AMPath21 attendees: make sure to take advantage of your access to the virtual meeting platform before it is gone! View the keynote lecture, scientific presentations & corporate workshops FREE through 11:59 PM ET tonight! ow.ly/40bA50GZIH6 #molpath
1
3
29 Nov 2021
Looking to learn about the latest technologies in molecular #pathology? Register for Get AMPed! - a virtual learning event (rescheduled from #AMPath21) on January 13. Learn more: ow.ly/Ci8550GYrVg #molpath
3
7
23 Nov 2021
The AMP 2021 meeting put the spotlight back on cancer, with emphasis on hard-to-detect cancer cells that remain in patients after treatment, according to an analysis by Bruce Carlson of @KaloramaInfo. #AMPath21 @AMPath #pathology bit.ly/3nS36bL
3
65
22 Nov 2021
Special thanks to the #AMPath21 Program Committee members and @AMPath staff who shifted course midstream and created an excellent Digital Experience last week! 👏👏Looking forward to the complete scientific meeting content which will be available in early 2022.
15 Nov 2021
Happy #AMPath21 Digital Experience week! We look forward to the select lectures and corporate workshops debuting this week, as well as seeing all the ePosters from our accepted abstract authors! ow.ly/3U8550GNRJh #molpath
6
22
Can automated #data mining provide insights into #genomic and therapeutic landscapes? We built a pipeline combining curated #RealWorld EMR data with #Sema4Signal NGS to assess the use of targeted therapies in a large patient population. Check out our poster at #AMPath21. @AMPath
8
19 Nov 2021
1
2
5
19 Nov 2021
An excellent summary by Dan Saul sharing the integration plan for Bionano’s optical genome mapping (OGM) data within our @BioDiscoveryInc NxClinical software, which will enable the most comprehensive interpretation of genomic variants in combination with NGS and arrays! #AMPath21
2
7
54
19 Nov 2021
BioDiscovery’s software reveals more of the tumor profile for enhanced transparency and clarity of chromosomal abnormalities to enable more accurate analysis of HRD. An outstanding example of how Bionano Genomics is transforming the way the world sees the genome! #AMPath21
2
10
53
19 Nov 2021
@BioDiscoveryInc NxClinical software is a proven, robust solution to detect genome-wide CNVs and LOH from array and NGS technologies, and soon OGM! An ideal tool for genomic scar classification for HRD analysis in #cancer samples!! #AMPath21
2
18
19 Nov 2021
Dan Saul, from @BioDiscoveryInc, is describing our NxClinical genome analysis software that integrates next-generation sequencing (NGS) and microarray data today, and soon OGM, providing the most comprehensive, consolidated interpretation of the genome! #AMPath21
4
8
69
19 Nov 2021
#AMPath21 Day 5 Digital experience @Agilent @loxooncology @Roche Characterizing Somatic Mutations in Non-Cancerous Cells
4
7
19 Nov 2021
Happening now at #AMPath21: "#Genomic characterization of advanced #prostatecancer: a view into metastatic subtypes and population heterogeneity," hosted by @Agilent Catch it live here: ow.ly/KtAQ50GRpWU #molpath
2
4
19 Nov 2021
Welcome to #AMPath21 Day 5! Today, we look forward to live corporate workshops from @Agilent @LillyPad & @Roche. In addition, don't miss @peter_j_park's presentation, "Characterizing somatic mutations in non-cancerous cells." ow.ly/Y9Nl50GRpNF #molpath
2
5
18 Nov 2021
To close out #AMPath21 Day 4, don't miss "Applications of Therapeutic #GeneEditing" with @UrnovFyodor & @hfrangoul Registration is free and we hope to "see" you there! ow.ly/sFJ750GQjCC #molpath
1
6